Cargando…

The Impacts of Systemic Immune-Inflammation Index on Clinical Outcomes in Gallbladder Carcinoma

Background: Systemic immune-inflammation index (SII) is considered to be a prognostic marker in several cancers. However, the prognostic value of baseline pre-operative SII in gallbladder carcinoma (GBC) has not been evaluated. This study aimed to determine the prognostic significance of SII and gen...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Lejia, Jin, Yukai, Hu, Wenmo, Zhang, Mengyuan, Jin, Bao, Xu, Haifeng, Du, Shunda, Xu, Yiyao, Zhao, Haitao, Lu, Xin, Sang, Xinting, Zhong, Shouxian, Yang, Huayu, Mao, Yilei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645045/
https://www.ncbi.nlm.nih.gov/pubmed/33194617
http://dx.doi.org/10.3389/fonc.2020.554521
_version_ 1783606583530356736
author Sun, Lejia
Jin, Yukai
Hu, Wenmo
Zhang, Mengyuan
Jin, Bao
Xu, Haifeng
Du, Shunda
Xu, Yiyao
Zhao, Haitao
Lu, Xin
Sang, Xinting
Zhong, Shouxian
Yang, Huayu
Mao, Yilei
author_facet Sun, Lejia
Jin, Yukai
Hu, Wenmo
Zhang, Mengyuan
Jin, Bao
Xu, Haifeng
Du, Shunda
Xu, Yiyao
Zhao, Haitao
Lu, Xin
Sang, Xinting
Zhong, Shouxian
Yang, Huayu
Mao, Yilei
author_sort Sun, Lejia
collection PubMed
description Background: Systemic immune-inflammation index (SII) is considered to be a prognostic marker in several cancers. However, the prognostic value of baseline pre-operative SII in gallbladder carcinoma (GBC) has not been evaluated. This study aimed to determine the prognostic significance of SII and generate a predictive nomogram. Methods: We retrospectively studied 142 GBC patients who underwent surgical resection at the Peking Union Medical College Hospital between 2003 and 2017. SII, neutrophil-to-lymphocyte ratio (NLR), and lymphocyte-to-monocyte ratio (LMR) were evaluated for their prognostic values. A multivariate Cox proportional hazards model was used for the recognition of significant factors. Then, the cohort was randomly divided into the training and the validation set. A nomogram was constructed using SII and other selected indicators in the training set. C-index, calibration plots, and decision curve analysis were performed to assess the nomogram's clinical utility in both the training and the validation set. Results: The predictive accuracy of SII (Harrell's concordance index [C-index]: 0.624), NLR (C-index: 0.626), and LMR (C-index: 0.622) was evaluated. The multivariate Cox model showed that SII was a superior independent predictor than NLR and LMR. SII level (≥600) (hazard ratio [HR]: 1.694, 95% confidence interval [CI]: 1.069–2.684, p = 0.024), carbohydrate antigen (CA) 19-9 level (≥37 U/ml) (HR: 2.407, 95% CI: 1.472–3.933, p < 0.001), and TNM stage (p = 0.026) were selected to construct a nomogram for predicting overall survival (OS). The predictive ability of this model was assessed by C-index (0.755 in the training set, 0.754 in the validation set). Good performance was demonstrated by the calibration plot. A high net benefit was proven by decision curve analysis (DCA). Conclusion: SII is an independent prognostic indicator in GBC patients after surgical resection, and the nomogram based on it is a useful tool for predicting OS.
format Online
Article
Text
id pubmed-7645045
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-76450452020-11-13 The Impacts of Systemic Immune-Inflammation Index on Clinical Outcomes in Gallbladder Carcinoma Sun, Lejia Jin, Yukai Hu, Wenmo Zhang, Mengyuan Jin, Bao Xu, Haifeng Du, Shunda Xu, Yiyao Zhao, Haitao Lu, Xin Sang, Xinting Zhong, Shouxian Yang, Huayu Mao, Yilei Front Oncol Oncology Background: Systemic immune-inflammation index (SII) is considered to be a prognostic marker in several cancers. However, the prognostic value of baseline pre-operative SII in gallbladder carcinoma (GBC) has not been evaluated. This study aimed to determine the prognostic significance of SII and generate a predictive nomogram. Methods: We retrospectively studied 142 GBC patients who underwent surgical resection at the Peking Union Medical College Hospital between 2003 and 2017. SII, neutrophil-to-lymphocyte ratio (NLR), and lymphocyte-to-monocyte ratio (LMR) were evaluated for their prognostic values. A multivariate Cox proportional hazards model was used for the recognition of significant factors. Then, the cohort was randomly divided into the training and the validation set. A nomogram was constructed using SII and other selected indicators in the training set. C-index, calibration plots, and decision curve analysis were performed to assess the nomogram's clinical utility in both the training and the validation set. Results: The predictive accuracy of SII (Harrell's concordance index [C-index]: 0.624), NLR (C-index: 0.626), and LMR (C-index: 0.622) was evaluated. The multivariate Cox model showed that SII was a superior independent predictor than NLR and LMR. SII level (≥600) (hazard ratio [HR]: 1.694, 95% confidence interval [CI]: 1.069–2.684, p = 0.024), carbohydrate antigen (CA) 19-9 level (≥37 U/ml) (HR: 2.407, 95% CI: 1.472–3.933, p < 0.001), and TNM stage (p = 0.026) were selected to construct a nomogram for predicting overall survival (OS). The predictive ability of this model was assessed by C-index (0.755 in the training set, 0.754 in the validation set). Good performance was demonstrated by the calibration plot. A high net benefit was proven by decision curve analysis (DCA). Conclusion: SII is an independent prognostic indicator in GBC patients after surgical resection, and the nomogram based on it is a useful tool for predicting OS. Frontiers Media S.A. 2020-10-23 /pmc/articles/PMC7645045/ /pubmed/33194617 http://dx.doi.org/10.3389/fonc.2020.554521 Text en Copyright © 2020 Sun, Jin, Hu, Zhang, Jin, Xu, Du, Xu, Zhao, Lu, Sang, Zhong, Yang and Mao. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Sun, Lejia
Jin, Yukai
Hu, Wenmo
Zhang, Mengyuan
Jin, Bao
Xu, Haifeng
Du, Shunda
Xu, Yiyao
Zhao, Haitao
Lu, Xin
Sang, Xinting
Zhong, Shouxian
Yang, Huayu
Mao, Yilei
The Impacts of Systemic Immune-Inflammation Index on Clinical Outcomes in Gallbladder Carcinoma
title The Impacts of Systemic Immune-Inflammation Index on Clinical Outcomes in Gallbladder Carcinoma
title_full The Impacts of Systemic Immune-Inflammation Index on Clinical Outcomes in Gallbladder Carcinoma
title_fullStr The Impacts of Systemic Immune-Inflammation Index on Clinical Outcomes in Gallbladder Carcinoma
title_full_unstemmed The Impacts of Systemic Immune-Inflammation Index on Clinical Outcomes in Gallbladder Carcinoma
title_short The Impacts of Systemic Immune-Inflammation Index on Clinical Outcomes in Gallbladder Carcinoma
title_sort impacts of systemic immune-inflammation index on clinical outcomes in gallbladder carcinoma
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645045/
https://www.ncbi.nlm.nih.gov/pubmed/33194617
http://dx.doi.org/10.3389/fonc.2020.554521
work_keys_str_mv AT sunlejia theimpactsofsystemicimmuneinflammationindexonclinicaloutcomesingallbladdercarcinoma
AT jinyukai theimpactsofsystemicimmuneinflammationindexonclinicaloutcomesingallbladdercarcinoma
AT huwenmo theimpactsofsystemicimmuneinflammationindexonclinicaloutcomesingallbladdercarcinoma
AT zhangmengyuan theimpactsofsystemicimmuneinflammationindexonclinicaloutcomesingallbladdercarcinoma
AT jinbao theimpactsofsystemicimmuneinflammationindexonclinicaloutcomesingallbladdercarcinoma
AT xuhaifeng theimpactsofsystemicimmuneinflammationindexonclinicaloutcomesingallbladdercarcinoma
AT dushunda theimpactsofsystemicimmuneinflammationindexonclinicaloutcomesingallbladdercarcinoma
AT xuyiyao theimpactsofsystemicimmuneinflammationindexonclinicaloutcomesingallbladdercarcinoma
AT zhaohaitao theimpactsofsystemicimmuneinflammationindexonclinicaloutcomesingallbladdercarcinoma
AT luxin theimpactsofsystemicimmuneinflammationindexonclinicaloutcomesingallbladdercarcinoma
AT sangxinting theimpactsofsystemicimmuneinflammationindexonclinicaloutcomesingallbladdercarcinoma
AT zhongshouxian theimpactsofsystemicimmuneinflammationindexonclinicaloutcomesingallbladdercarcinoma
AT yanghuayu theimpactsofsystemicimmuneinflammationindexonclinicaloutcomesingallbladdercarcinoma
AT maoyilei theimpactsofsystemicimmuneinflammationindexonclinicaloutcomesingallbladdercarcinoma
AT sunlejia impactsofsystemicimmuneinflammationindexonclinicaloutcomesingallbladdercarcinoma
AT jinyukai impactsofsystemicimmuneinflammationindexonclinicaloutcomesingallbladdercarcinoma
AT huwenmo impactsofsystemicimmuneinflammationindexonclinicaloutcomesingallbladdercarcinoma
AT zhangmengyuan impactsofsystemicimmuneinflammationindexonclinicaloutcomesingallbladdercarcinoma
AT jinbao impactsofsystemicimmuneinflammationindexonclinicaloutcomesingallbladdercarcinoma
AT xuhaifeng impactsofsystemicimmuneinflammationindexonclinicaloutcomesingallbladdercarcinoma
AT dushunda impactsofsystemicimmuneinflammationindexonclinicaloutcomesingallbladdercarcinoma
AT xuyiyao impactsofsystemicimmuneinflammationindexonclinicaloutcomesingallbladdercarcinoma
AT zhaohaitao impactsofsystemicimmuneinflammationindexonclinicaloutcomesingallbladdercarcinoma
AT luxin impactsofsystemicimmuneinflammationindexonclinicaloutcomesingallbladdercarcinoma
AT sangxinting impactsofsystemicimmuneinflammationindexonclinicaloutcomesingallbladdercarcinoma
AT zhongshouxian impactsofsystemicimmuneinflammationindexonclinicaloutcomesingallbladdercarcinoma
AT yanghuayu impactsofsystemicimmuneinflammationindexonclinicaloutcomesingallbladdercarcinoma
AT maoyilei impactsofsystemicimmuneinflammationindexonclinicaloutcomesingallbladdercarcinoma